Wednesday, May 21, 2014

New State of the Art Laboratory Technology at The Medical Foundation Laboratory in Logansport Memorial Hospital

The Medical Foundation Laboratory at Logansport Memorial Hospital has enhanced its laboratory capabilities to respond to physician requests for blood tests with new equipment. 
Laboratory administrators recently unveiled the new instrument at a ribbon-cutting ceremony attended by lab and hospital employees. This new system, called the cobas® 6000 analyzer series, analyzes blood samples for routine and innovative chemistry tests ordered by physicians.

Officials from the Roche Group, The Medical Foundation stand with leadership and laboratory employees from Logansport Memorial Hospital, preparing to cut the ribbon on using new state-of-the-art cobas 6000 analyzers.

“The cobas 6000 analyzer series will make our lab much more efficient,” said Robert Tomec, M.D. and President of The Medical Foundation.  “This system provides broad testing capability to continue to enhance our practice of laboratory medicine for years to come. This is just another step in our commitment to continuously improve our quality of patient care, while providing our medical staff with the tools they need.”

This highly compact system consolidates more than 95% of routine testing, therefore requiring fewer analyzers, which optimizes lab staff efficiency.

“We receive more than 57,000 test requests per month, and that demand is continuing to grow,” said Diane Janowiak, Vice President of Operations at The Medical Foundation. “Therefore, we found ourselves needing to accomplish more every day, and it was beginning to take a toll on our personnel resources and aging equipment. With increased demand, we knew we needed to make improvements in order to maintain our goal of producing fast and accurate test results.”

“Our partnership with The Medical Foundation continues to serve us well, but more importantly, it continues to serve our patients well,” comments David Ameen, President and CEO of Logansport Memorial Hospital. “Installing state-of-the-art equipment like these analyzers gives our physicians additional access to enhanced testing methods that may be beneficial for our patients. Having the ability to perform these tests on-site and receive timely results is another exceptional feature of installing this type of updated equipment. We are fortunate to have this partnership in place to respond to physician needs in providing high-quality patient care.”

Manufactured by Roche Diagnostics, the cobas 6000 analyzer series integrates multiple technologies to give us efficiency and the flexibility to grow as our needs change. 
Upgrading the laboratory was a tremendous task, however, according to Janowiak, the transition was so smooth that few people in the hospital noticed it was going on.

“Whenever you take on this type of project, you worry how it will affect the daily workload and if it will slow down the process,” said Janowiak.  “However, the entire process was painless thanks in large part to Roche Diagnostics. Their team kept everything moving on schedule without interfering with our normal day-to-day processes.” 

About Roche
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.  As the world’s biggest biotech company and innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people’s health and quality of life.  Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.  In 2006 sales by the Pharmaceuticals Division totaled 33.3 billion Swiss francs, and the Diagnostic Division posted sales of 8.7 billion Swiss francs.  Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invests approximately 7 billion Swiss francs a year in R&D.  Worldwide, the Group employs about 75,000 people.  Additional information is available on the Internet in the U.S. at www.roche-diagnostics.us or globally at www.roche.com.

About The Medical Foundation
The Medical Foundation is a nationally recognized non-profit laboratory system that has played a major role in the continuing technological evolution of laboratory science for over 100 years.  Located in Northern Indiana, the Foundation serves over 1,250 clients including hospitals, general physician and specialty practices and surgicenters throughout Indiana, Michigan, Ohio and Illinois.  The Medical Foundation provides services in areas such as Blood Bank, Centralized Chemistry, Hematology, Immunology, Molecular Genetics, Microbiology, Cytology and Flow Cytometry.  In January 2014, the Foundation reached an agreement with Logansport Memorial Hospital to begin managing the laboratory at the hospital.  This agreement came after a 15 year relationship with The Medical Foundation providing top-quality, cost-effective health services.  

No comments:

Post a Comment